First human test for new sickle cell pill begins
Knowledge-focused
Recruiting now
This is an early safety study to see how the body absorbs and processes a new tablet called pociredir in people with sickle cell disease. It will enroll about 24 participants to test the drug when taken on an empty stomach and after a meal. The main goal is to measure the drug's …
Phase: PHASE1 • Sponsor: Fulcrum Therapeutics • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:26 UTC